GEG Tech launches a series of collaborations with leading research institutions to enable high-precision gene therapy based on genome editing
GEG Tech announces the release of a new mRNA vector technology, designed to deliver novel prime and base editing systems. Leading research institutions in the field of genome editing, including the Broad Institute of MIT and Harvard, have initiated collaborations with GEG Tech to test the technology with their own systems. The objective is to shape the future of gene therapy, with a new generation of high-precision, high-efficacy and high-safety treatments.
To receive the link to PDF version of the press release, please enter your email address:
